Dynamic Scoring: A Progress Report on Why, When, and How
Brookings Papers on Economic Activity · 2024-09 · 2024 (2) · 93-160
DOI: 10.1353/eca.2024.a964370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brookings Papers on Economic Activity, 2024-09. Verfasst von Douglas Elmendorf und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
By design, official budget estimates for legislative proposals generally exclude the proposals' likely effects on labor, capital, productivity, and output, as well as any feedback from such effects to the federal budget. Policymakers would benefit from knowing the expected sizes of those effects, and advances in research and in the estimating agencies' tools and experience have made such analysis more feasible. If Congress requested that those effects be included more often in official budget estimates—so-called dynamic scoring of legislation—the advantages and disadvantages would vary across policy areas. For some areas, the estimated budgetary impact of the currently excluded effects would be significantly different from the impact of the included effects. But dynamic scoring would be substantially more time-consuming than conventional scoring, and in some areas, the research base is insufficient for credible estimation.
Zitieren
APA
Elmendorf, D., Hubbard, G., & Williams, H. (2024). Dynamic Scoring: A Progress Report on Why, When, and How. Brookings Papers on Economic Activity, 2024(2), 93-160. https://doi.org/10.1353/eca.2024.a964370
Vancouver
Elmendorf D, Hubbard G, Williams H. Dynamic Scoring: A Progress Report on Why, When, and How. Brookings Papers on Economic Activity. 2024;2024(2):93-160. doi:10.1353/eca.2024.a964370
BibTeX
@article{Elmendorf2024,
author = {Elmendorf, Douglas and Hubbard, Glenn and Williams, Heidi},
title = {Dynamic Scoring: A Progress Report on Why, When, and How},
journal = {Brookings Papers on Economic Activity},
year = {2024},
volume = {2024},
number = {2},
pages = {93--160},
doi = {10.1353/eca.2024.a964370}
}
EUVIMED